project id: TCGA-BLCA; case submitter id: TCGA-KQ-A41R; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 8.3; age at index: 80; days to birth: -29351; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 29351; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1350.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; initial weight: 240.0; sample id: d25c4cba-553c-459a-9249-433726b84c3a; sample submitter id: TCGA-KQ-A41R-01A; portion id: 89cfcbfb-0542-44dd-b03f-948230a4c339; portion submitter id: TCGA-KQ-A41R-01A-21; slide id: f0d171df-67af-427b-8eef-c33eda93536c; slide submitter id: TCGA-KQ-A41R-01A-02-TSB; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0; section location: TOP;